Advisory
Commission on Childhood Vaccines (ACCV)
The
ACCV advises and makes recommendations
to the Secretary of Health and Human Services
on issues relating to the operation of
the National Vaccine Injury Compensation
Program (VICP). There are nine voting
members who provide oversight of the VICP
and recommend ways to improve the VICP.
2008 Draft Strategic National Vaccine
Plan
The 2008 draft strategic National Vaccine
Plan is the initial step in updating the
1994 National Vaccine Plan. The National
Vaccine Program Office (NVPO) coordinated
the planning effort with (your Agency/Office),
other HHS agencies, the Departments of Defense
and Veterans Affairs, and the U.S. Agency
for International Development. The
National Vaccine Program Office website
describes the process in more detail in
the Introduction document, and the draft
Plan can be reviewed there. NVPO is seeking
comments about the draft Plan from interested
stakeholders and the public. If you have
comments, please email NVPO at nvpo@hhs.gov.
2009
Meetings
March
5-6, 2009
June 11-12, 2009
September 10-11, 2009
December 3-4, 2009
Minutes
from 2008
Meetings
Minutes
from 2007
Meetings
Minutes
from 2006
Meetings
ACCV
Roster
Charter
Purpose
The
Secretary of Health and Human Services
is mandated under Section 2119 of the
Public Health Service (PHS) Act to appoint
an advisory commission to give advice
regarding the National Vaccine Injury
Compensation Program (the Program), which
provides compensation for certain vaccine-related
injuries or deaths. The Advisory Commission
on Childhood Vaccines (hereinafter referred
to as the "Commission") shall
advise and make recommendations to the
Secretary on matters related to the Program
responsibilities.
Authority
42
U.S.C. 300aa-19, Section 2119 of the PHS
Act. The Commission is governed by the
provisions of Public Law 92-463 (5 U.S.C.
App. 2), which sets forth standards for
the formation of advisory committees.
Functions
The Commission shall:
(1)
advise the Secretary on the implementation
of the Program;
(2)
on its own initiative or as the result
of the filing of a petition, recommend
changes in the Vaccine Injury Table;
(3)
advise the Secretary in implementing
the Secretary's responsibilities under
Section 2127 of the PHS Act regarding
the need for childhood vaccination products
that result in fewer or no significant
adverse reactions;
(4)
survey Federal, State, and local programs
and activities relating to the gathering
of information on injuries associated
with the administration of childhood
vaccines, including the adverse reaction
reporting requirements of Section 2125(b),
and advise the Secretary on means to
obtain, compile, publish, and use credible
data related to the frequency and severity
of adverse reactions associated with
childhood vaccines;
(5)
recommend to the Director of the National
Vaccine Program research related to
vaccine injuries which should be conducted
to carry out the Program; and
(6)
consult regarding the development or
revision of vaccine information materials
as required by Section 2126 of the PHS
Act.
Structure
The Commission shall be composed of
the following:
(1)
Nine members appointed by the Secretary
as follows:
(A)
Three members who are health professionals,
who are not employees of the United
States, and who have expertise in
the health care of children, the epidemiology,
etiology, and prevention of childhood
diseases, and the adverse reactions
associated with vaccines, of whom
at least two shall be pediatricians.
(B)
Three members from the general public,
of whom at least two shall be legal
representatives of children who have
suffered a vaccine-related injury
or death.
(C)
Three members who are attorneys, of
whom at least one shall be an attorney
whose specialty includes representation
of persons who have suffered a vaccine-related
injury or death and of whom one shall
be an attorney whose specialty includes
representation of vaccine manufacturers.
(2)
The Director of the National Institutes
of Health, the Assistant Secretary for
Health, the Director of the Centers
for Disease Control and Prevention,
and the Commissioner of the Food and
Drug Administration (or the designees
of such officials), each of whom shall
be a nonvoting ex officio member.
The
Secretary shall select members of the
Commission. The members of the Commission
shall select a Chair and Vice Chair from
among the members. Appointed members of
the Commission shall be appointed for
a term of office of 3 years. Members may
serve after the expiration of their term
until their successors have taken office.
Subcommittees
will be established from time to time.
Upon establishment of each subcommittee,
the Department's Committee Management
Officer will be provided information on
the subcommittee's name, membership, function,
and estimated frequency of meetings.
Management
and support services shall be provided
by the Division of Vaccine Injury Compensation,
Healthcare
Systems Bureau,
Health Resources and Services Administration.
Meetings
The Commission shall meet not less than
4 times per year and at the call of the
designated federal officer or designee
who shall approve the agenda and shall
be present at all meetings. A quorum for
the purposes of a meeting is five. A decision
at a meeting is to be made by a majority
of the voting members present, rather
than an absolute majority of voting members.
Meetings
shall be open to the public except as
determined by the Secretary or other officials
to whom the authority has been delegated
in accordance with the Government in the
Sunshine Act (5 U.S.C. 552b(c)). Notice
of all meetings shall be given to the
public.
Meetings
shall be conducted and records of the
proceedings kept, as required by applicable
laws and departmental regulations.
Compensation
Members of the Commission who are
officers or employees of the Federal Government
shall serve as members of the Commission
without compensation in addition to that
received in their regular public employment.
Members of the Commission who are not
officers or employees of the Federal Government
shall be compensated at a rate not to
exceed the daily equivalent of the rate
in effect for an Executive Level 4 for
each day (including travel time) they
are engaged in the performance of their
duties as members of the Commission. All
members, while so serving away from their
homes or regular places of business, may
be allowed travel expenses, including
per diem in lieu of subsistence, in the
same manner as such expenses are authorized
by 5 U.S.C 5703 for employees serving
intermittently.
Annual
Cost Estimates
Estimated annual cost for operating
the Commission, including compensation
and travel expenses for members, but excluding
staff support, is approximately $95,509.
The estimate of annual person-years of
staff support required is 1.5 at an estimated
annual cost of $303,271.
Reports
In the event a portion of a meeting
is closed to the public, as determined
by the Secretary of HHS, in accordance
with the Government in the Sunshine Act
(5 U.S.C. 552b(c)) and the Federal Advisory
Committee Act, a
report shall be prepared which shall contain
as a minimum, a list of members and their
business addresses, the Commission's functions,
dates and places of meetings, and a summary
of Commission activities and recommendations
made during the fiscal year. A copy of
the report shall be provided to the Departmental
Committee Management Officer.
Termination
Date
Unless renewed by appropriate action
prior to its expiration, this charter
will expire on July 21, 2010.
APPROVED:
Date |
Wendy
Ponton
Director, Office of Management
|
This
information reflects the current thinking of the United States Department
of Health and Human Services on the topics addressed. This information is
not legal advice and does not create or confer any rights for or on any
person and does not operate to bind the Department or the public. The ultimate
decision about the scope of the statutes authorizing the VICP is within
the authority of the United States Court of Federal Claims, which is responsible
for resolving claims for compensation under the VICP.
|
|